Pictet Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$56.9M Buy
251,833
+178,415
+243% +$40M 0.06% 290
2025
Q4
$15.5M Sell
73,418
-3,640
-5% -$752K 0.02% 580
2025
Q3
$14.8M Sell
77,058
-8,480
-10% -$1.58M 0.01% 593
2025
Q2
$14.7M Sell
85,538
-21,220
-20% -$3.46M 0.02% 581
2025
Q1
$16.5M Sell
106,758
-37,441
-26% -$5.35M 0.02% 542
2024
Q4
$19.9M Sell
144,199
-9,845
-6% -$1.29M 0.02% 505
2024
Q3
$22.3M Buy
154,044
+7,717
+5% +$1.04M 0.02% 466
2024
Q2
$20M Sell
146,327
-124,443
-46% -$16.9M 0.02% 465
2024
Q1
$40.9M Buy
270,770
+67,116
+33% +$9.58M 0.04% 347
2023
Q4
$25.7M Buy
203,654
+32,784
+19% +$3.27M 0.03% 419
2023
Q3
$16M Buy
+170,870
New +$16M 0.02% 520

Other funds holding ASND